Miyu Kano

BAFF inhibition attenuates fibrosis in scleroderma by modulating the regulatory and effector B cell balance

Takashi Matsushita, Tadahiro Kobayashi, Kie Mizumaki et al. · Science Advances · 2018 · 140 citations · Full text

Life Sciences, Immunology, Pathology +17

Immunomodulating role of the JAKs inhibitor tofacitinib in a mouse model of bleomycin-induced scleroderma

Wah Wah Aung, Chenyang Wang, Motoki Horii et al. · Journal of Dermatological Science · 2020 · 43 citations · Full text

Medicine, Immunology, Pharmacology +11

Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells

Kie Mizumaki, Motoki Horii, Miyu Kano et al. · Scientific Reports · 2021 · 36 citations · Full text

Life Sciences, Dermatology, Immunology +17

Blockade of p38 Mitogen-Activated Protein Kinase Inhibits Murine Sclerodermatous Chronic Graft-versus-Host Disease

Takashi Matsushita, Mutsumi Date, Miyu Kano et al. · American Journal Of Pathology · 2017 · 28 citations · Full text

Life Sciences, Immunology, Pathobiology +10

Elevated serum B‐cell activating factor levels in patients with dermatomyositis: Association with interstitial lung disease

Takashi Matsushita, Tadahiro Kobayashi, Miyu Kano et al. · The Journal of Dermatology · 2019 · 28 citations

Life Sciences, Immunology, Pathology +17